Prevalence of group B Streptococcus colonization in pregnant women and serotype specific immunity among mother-newborns dyads in Ghana and Zimbabwe

BACKGROUND: Rectovaginal colonization with Streptococcus agalactiae (Group B Streptococcus; GBS) during pregnancy is a major risk factor for neonatal invasive GBS disease and adverse birth outcomes. We investigated the prevalence of maternal GBS colonization, serotype-specific immunoglobulin G (IgG) immunity in mother-newborn dyads, and GBS associated stillbirths in Ghana and Zimbabwe. METHODS: A prospective cohort of 1238 pregnant women and their infants was enrolled (2018-2020). Recto-vaginal swabs collected at ≥36 weeks gestation or prior to delivery and chest aspirates from stillbirths were cultured for GBS. Isolates were serotyped using latex agglutination. Maternal and cord blood samples were analysed for GBS serotype-specific IgG using a multiplex bead-based immunoassay. RESULTS: The prevalence of recto-vaginal GBS colonization was 15.6% (68/437) in Ghana and 15.2% (50/329) in Zimbabwe. GBS was detected in 33.3% (3/9) of stillbirths. Dominant colonizing serotypes were Ia (25%), III (32%), and V (27%). Maternal IgG concentrations were significantly higher in Ghana than in Zimbabwe for serotypes Ib (0.11 vs 0.02 μg/mL; p = 0.0001), II (0.24 vs 0.06 μg/mL; p = 0.0001), and IV (0.03 vs 0.006 μg/mL; p < 0.0001). Transplacental IgG transfer ratios ranged from 0.81 to 1.08; highest for serotype II and lowest for Ia. Newborns with IgG above the serological thresholds for risk reduction for serotype Ia and III were 25.6% (Ia) and 38.4% (III) in Ghana; and 34.1% (Ia) and 26.8% (III) in Zimbabwe. CONCLUSIONS: The predominant GBS serotypes distribution in Ghana and Zimbabwe aligns with global epidemiological patterns. Despite evidence of natural maternal IgG immunity and efficient transplacental transfer, most newborns lacked protective antibody levels against GBS. A maternal GBS vaccine targeting dominant serotypes may reduce the risk of GBS neonatal invasive disease and GBS-associated stillbirths.

Authors

Institutions

Publication Details

Journal
Vaccine
Published
2026-04-26
DOI
https://doi.org/10.1016/j.vaccine.2026.128626
Primary Topic
Neonatal and Maternal Infections
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence of group B Streptococcus colonization in pregnant women and serotype specific immunity among mother-newborns dyads in Ghana and Zimbabwe

Irene Apewe Adjei, Gaurav Kwatra, Oscar Agyei, Zivai Mupambireyi et al.
Vaccine
Neonatal and Maternal Infections
article

Prevalence of group B Streptococcus colonization in pregnant women and serotype specific immunity among mother-newborns dyads in Ghana and Zimbabwe

Irene Apewe Adjei, Gaurav Kwatra, Oscar Agyei, Zivai Mupambireyi, Nisha Dhar, Kwaku Poku Asante, F. Cowan, Jones Opoku-Mensah, Matthews Mathai, Edward Matsikire, Elizabeth Mathai, Sam Newton, Yeetey Akpe Enuameh, Luis Cuevas, Alex Manu, Louisa Iddrisu, Andrew Carey, Sarah A. White
article en

Abstract

BACKGROUND: Rectovaginal colonization with Streptococcus agalactiae (Group B Streptococcus; GBS) during pregnancy is a major risk factor for neonatal invasive GBS disease and adverse birth outcomes. We investigated the prevalence of maternal GBS colonization, serotype-specific immunoglobulin G (IgG) immunity in mother-newborn dyads, and GBS associated stillbirths in Ghana and Zimbabwe. METHODS: A prospective cohort of 1238 pregnant women and their infants was enrolled (2018-2020). Recto-vaginal swabs collected at ≥36 weeks gestation or prior to delivery and chest aspirates from stillbirths were cultured for GBS. Isolates were serotyped using latex agglutination. Maternal and cord blood samples were analysed for GBS serotype-specific IgG using a multiplex bead-based immunoassay. RESULTS: The prevalence of recto-vaginal GBS colonization was 15.6% (68/437) in Ghana and 15.2% (50/329) in Zimbabwe. GBS was detected in 33.3% (3/9) of stillbirths. Dominant colonizing serotypes were Ia (25%), III (32%), and V (27%). Maternal IgG concentrations were significantly higher in Ghana than in Zimbabwe for serotypes Ib (0.11 vs 0.02 μg/mL; p = 0.0001), II (0.24 vs 0.06 μg/mL; p = 0.0001), and IV (0.03 vs 0.006 μg/mL; p < 0.0001). Transplacental IgG transfer ratios ranged from 0.81 to 1.08; highest for serotype II and lowest for Ia. Newborns with IgG above the serological thresholds for risk reduction for serotype Ia and III were 25.6% (Ia) and 38.4% (III) in Ghana; and 34.1% (Ia) and 26.8% (III) in Zimbabwe. CONCLUSIONS: The predominant GBS serotypes distribution in Ghana and Zimbabwe aligns with global epidemiological patterns. Despite evidence of natural maternal IgG immunity and efficient transplacental transfer, most newborns lacked protective antibody levels against GBS. A maternal GBS vaccine targeting dominant serotypes may reduce the risk of GBS neonatal invasive disease and GBS-associated stillbirths.

VaccineVol. 82
South African Medical Research Council (ZA), Christian Medical College, Vellore (IN), Liverpool School of Tropical Medicine (GB), Kwame Nkrumah University of Science and Technology (GH), Centre for Sexual Health and HIV AIDS Research (ZW), Kintampo Health Research Centre (GH), Ghana Health Service (GH), University of Cincinnati Medical Center (US)
European Commission
Good health and well-being
Openalex Percentile: Top 15%
Neonatal and Maternal Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.